Luka Milas

1.7k total citations
41 papers, 1.4k citations indexed

About

Luka Milas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Luka Milas has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Luka Milas's work include Cancer Treatment and Pharmacology (8 papers), Cancer-related Molecular Pathways (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Luka Milas is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Cancer-related Molecular Pathways (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Luka Milas collaborates with scholars based in United States, Japan and Taiwan. Luka Milas's co-authors include Nancy Hunter, Christopher Milross, L.J. Peters, K.A. Mason, Wan Kyun Chung, K. Kian Ang, Thomas Barkley, Elizabeth R. Hall, Yoshitaka Furuta and L. Clifton Stephens and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, International Journal of Radiation Oncology*Biology*Physics and International Journal of Cancer.

In The Last Decade

Luka Milas

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luka Milas United States 19 643 489 376 257 230 41 1.4k
Lars Damstrup Denmark 19 910 1.4× 902 1.8× 452 1.2× 226 0.9× 208 0.9× 43 1.9k
K.A. Mason United States 11 687 1.1× 288 0.6× 440 1.2× 228 0.9× 123 0.5× 18 1.3k
B. Helfrich United States 13 726 1.1× 698 1.4× 581 1.5× 294 1.1× 193 0.8× 27 1.4k
Rosa Caputo Italy 20 1.3k 2.1× 1.0k 2.1× 906 2.4× 355 1.4× 218 0.9× 21 2.3k
Cataldo Bianco Italy 24 765 1.2× 757 1.5× 427 1.1× 252 1.0× 169 0.7× 37 1.5k
Cordula Petersen Germany 26 870 1.4× 1.0k 2.1× 435 1.2× 493 1.9× 212 0.9× 60 2.0k
J.R. Woodburn United Kingdom 11 948 1.5× 701 1.4× 614 1.6× 144 0.6× 192 0.8× 14 1.7k
Nobuya Yamada Japan 18 579 0.9× 379 0.8× 148 0.4× 292 1.1× 66 0.3× 74 1.1k
E Kr̆epela Czechia 20 710 1.1× 499 1.0× 424 1.1× 384 1.5× 113 0.5× 46 1.5k
Dongwei Zhang United States 16 733 1.1× 589 1.2× 284 0.8× 281 1.1× 113 0.5× 64 1.5k

Countries citing papers authored by Luka Milas

Since Specialization
Citations

This map shows the geographic impact of Luka Milas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luka Milas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luka Milas more than expected).

Fields of papers citing papers by Luka Milas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luka Milas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luka Milas. The network helps show where Luka Milas may publish in the future.

Co-authorship network of co-authors of Luka Milas

This figure shows the co-authorship network connecting the top 25 collaborators of Luka Milas. A scholar is included among the top collaborators of Luka Milas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luka Milas. Luka Milas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raju, Uma, Hisanori Ariga, Masashi Koto, et al.. (2006). 152 Improvement of esophageal adenocarcinoma cell and xenograft responses to chemoradiation by targeting cyclin-dependent kinases. Radiotherapy and Oncology. 78. S51–S51. 1 indexed citations
2.
Milas, Luka, et al.. (2005). Targeting Molecular Determinants of Tumor Chemo-Radioresistance. Seminars in Oncology. 32(6 Suppl 9). 78–81. 41 indexed citations
3.
Raben, David, Cataldo Bianco, Luka Milas, & K. Kian Ang. (2004). Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?. Seminars in Radiation Oncology. 14(2). 139–152. 16 indexed citations
4.
Mason, Kathryn A., Alexander Staab, Nancy Hunter, et al.. (2001). Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. International Journal of Oncology. 18(3). 599–606. 49 indexed citations
5.
Nasu, Sachiko, K. Kian Ang, Zhen Fan, & Luka Milas. (2001). C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. International Journal of Radiation Oncology*Biology*Physics. 51(2). 474–477. 116 indexed citations
6.
Milas, Luka, et al.. (2000). [Recent studies on anti-angiogenesis in cancer therapy].. PubMed. 58(8). 1747–62. 2 indexed citations
7.
Oriuchi, Noboru, Luka Milas, E. Edmund Kim, et al.. (2000). Assessment of resistance to paclitaxel of murine tumors by 99mTc-MIBI/201Tl dual-radionuclide imaging. Nuclear Medicine and Biology. 27(2). 127–133. 2 indexed citations
8.
Li, Chun, Ke Shi, Wayne Tansey, et al.. (2000). Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate. International Journal of Radiation Oncology*Biology*Physics. 48(4). 1119–1126. 22 indexed citations
9.
Akimoto, Tetsuo, Shinichiro Kawabe, Axel Grothey, & Luka Milas. (1999). Low E-cadherin and β-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas. Clinical & Experimental Metastasis. 17(2). 171–176. 9 indexed citations
10.
Mason, Kathy A., Luka Milas, Nancy Hunter, et al.. (1999). Maximizing therapeutic gain with gemcitabine and fractionated radiation. International Journal of Radiation Oncology*Biology*Physics. 44(5). 1125–1135. 90 indexed citations
11.
Logsdon, Mark D., Raymond E. Meyn, Pelayo Besa, et al.. (1999). Apoptosis and the BCL-2 gene family - patterns of expression and prognostic value in STAGE I and II follicular center lymphoma. International Journal of Radiation Oncology*Biology*Physics. 44(1). 19–29. 17 indexed citations
12.
Komaki, Ritsuko, Luka Milas, Jae Y. Ro, et al.. (1998). Prognostic Biomarker Study in Pathologically Staged N1 Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 40(4). 787–796. 26 indexed citations
13.
Seong, Jinsil, et al.. (1997). Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-??. Anti-Cancer Drugs. 8(1). 80–87. 8 indexed citations
14.
Yang, David J., Sidney Wallace, Abdallah Cherif, et al.. (1996). Evaluation of [131l]iodoerythronitroimidazole as a predictor for the radiosensitizing effect. Anti-Cancer Drugs. 7(8). 858–865.
15.
Milross, Christopher, K.A. Mason, Nancy Hunter, et al.. (1996). Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of Paclitaxel. JNCI Journal of the National Cancer Institute. 88(18). 1308–1314. 252 indexed citations
16.
Meyn, Raymond E., L. Clifton Stephens, Nancy Hunter, & Luka Milas. (1995). Kinetics of cisplatin‐induced apoptosis in murine mammary and ovarian adenocarcinomas. International Journal of Cancer. 60(5). 725–729. 48 indexed citations
17.
Milas, Luka, et al.. (1994). Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide. Radiotherapy and Oncology. 30(3). 247–253. 36 indexed citations
18.
Meyn, Raymond E., L. Clifton Stephens, Nancy Hunter, & Luka Milas. (1994). Induction of apoptosis in murine tumors by cyclophosphamide. Cancer Chemotherapy and Pharmacology. 33(5). 410–414. 51 indexed citations
19.
20.
Serša, Gregor, V. Willingham, & Luka Milas. (1988). Anti‐tumor effects of tumor necrosis factor alone or combined with radiotherapy. International Journal of Cancer. 42(1). 129–134. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Damstrup Breakdown of academic impact, for papers by K.A. Mason Breakdown of academic impact, for papers by B. Helfrich Breakdown of academic impact, for papers by Rosa Caputo Breakdown of academic impact, for papers by Cataldo Bianco Breakdown of academic impact, for papers by Cordula Petersen Breakdown of academic impact, for papers by J.R. Woodburn Breakdown of academic impact, for papers by Nobuya Yamada Breakdown of academic impact, for papers by E Kr̆epela Breakdown of academic impact, for papers by Dongwei Zhang
Rankless by CCL
2026